According to the latest report by Reports and Data, the global Epinephrine Market size is expected to reach USD 4.76 Billion by 2028, growing at a CAGR of 8.7%. The increasing demand for epinephrine auto-injectors for quick emergency response, rising incidences of severe allergic reactions and anaphylactic shock, and technological advancements in epinephrine injectors are key factors driving the growth of the market.

Epinephrine is widely used to restore cardiac rhythm, control asthma, and treat life-threatening allergic reactions, which is boosting demand for epinephrine products and expected to contribute to market growth in the future.

Get a free sample PDF of the report, visit @

https://www.reportsanddata.com/download-free-sample/91

Epinephrine is a hormone and neurotransmitter that has vasoconstricting, intraocular pressure-reducing, and bronchodilating activities. It is widely used as a medication and hormone and has been approved by the FDA for the treatment of type 1 hypersensitivity reaction, cardiac arrest, and asthma attacks. Epinephrine plays an important role in the fight-or-flight response by increasing blood flow to muscles. The administration of epinephrine varies based on the diagnosis, such as intravenous injection, injection into muscles, inhalation, or injection just under the skin.

The increasing demand for epinephrine auto-injectors for quick emergency response is expected to be a key driving factor for market growth. However, the side effects of epinephrine such as high blood pressure, headache, abnormal heart rhythm, and anxiety may hinder market growth to some extent over the forecast period.

To know more about the latest insights of the report, visit @

https://www.reportsanddata.com/request-latest-insight/91

The report highlights that the epinephrine auto-injector segment is expected to register significant revenue growth over the forecast period, owing to the growing demand for prefilled auto-injectors, launch of affordable generic epinephrine products, and innovations in auto-injectors. The anaphylaxis segment is expected to account for a significant share in the global market, owing to the increasing incidence of anaphylactic allergic reactions and an increasing number of people susceptible to allergies. Epinephrine is the primary treatment approach for anaphylaxis.

North America is expected to account for the largest revenue share in the global market, owing to the increasing number of people with life-threatening food allergies, a rise in chronic illnesses due to allergies, the presence of robust healthcare facilities, and the rapid launch of advanced epinephrine injections and products.

Key companies in the market include Abbott Laboratories, Lincoln Medical, Ltd., Mylan, Inc., Sanofi SA, Amedra Pharmaceuticals LLC, and ALK Abello A/S.

In June 2021, Alerje Inc. introduced a smartphone case equipped with an auto-injector that rapidly releases epinephrine during severe allergic reactions. The case also automatically alters the patient's support circle through the Alerje smartphone app when a dose is discharged from the case.

The report segmented the global epinephrine market on the basis of type, application, and region. The type outlook includes epinephrine auto-injector, epinephrine prefilled syringe, and others. The application outlook includes anaphylaxis and others. The regional outlook includes North America (U.S., Canada, Mexico), Europe (Germany, U.K., France, Italy, BENELUX), Asia Pacific (China, India, Japan, South Korea, Rest of APAC), Latin America (Brazil, Rest of Latin America), and the Middle East Africa (U.A.E., Saudi Arabia, South Africa, Rest of MEA).

Request a customized copy of the report @

https://www.reportsanddata.com/request-customization-form/91

Thank you for reading our report. To inquire about customization or any query about the report, please get in touch with us. Our team will make sure the report is best suited to your needs.  

About Reports and Data 

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behaviour shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.

Contact:

John W, Head of Business Development
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
LinkedIn | Twitter | Blogs

Browse for more reports…

https://www.reportsanddata.com/report-detail/drug-delivery-devices-market

https://www.reportsanddata.com/report-detail/mammography-workstation-market